Nuclear imaging and biomarkers in drug development using approved radiopharmaceuticals

Journal of Clinical Pharmacology

Volumn 41, Issue 7 SUPPL., 2001, Pages

  Eckelman, William C ^a   Waterhouse, Rikki ^b   Frank, Richard ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CONFERENCE PAPER; DRUG LABELING; DRUG RESEARCH; DRUG UPTAKE; IMAGING; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; CLINICAL PHARMACOLOGY; DRUG APPROVAL; EDITORIAL; METHODOLOGY; SCINTISCANNING;

BIOLOGICAL MARKERS; DRUG APPROVAL; PHARMACOLOGY, CLINICAL; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 0034743488     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127001773744080     Document Type: Conference Paper

References (18)

1. Proceedings: Use of imaging in drug R&D
2. The Alfred P. Wolf Award
3. 18FDG for the study of central nervous system drugs
4. 15O]water be used to evaluate drugs?
5. Imaging cellular proliferation as a measure of response to therapy
6. 18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography
7. Quantitative analysis of tumor biochemistry using PET and SPECT
8. Prospects for human pharmacological functional magnetic resonance imaging (phMRI)
9. Reversal of multidrug resistance with LY335979: Functional analysis of P-glycoprotein-mediated transport activity and its modulation in vivo
10. 99mTc-Tetrofosmin for functional imaging of P-glycoprotein modulation in vivo
11. P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography
12. Monitoring disease progression in Parkinson's disease
13. Neuroimaging and drug development: An algorithm for decision making
14. 1A receptor imaging in the human brain with positron-emission tomography: Coordination of the standardization and dissemination of methodology
15. Immunological and molecular analysis of the sentinel lymph node: A potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development
16. The use of microPET for the development of neural repair therapeutics: Studies in epilepsy and lesion models
17. Positron-emission tomography tracers as intellectual property
18. The use of imaging as biomarkers in drug development: Regulatory issues worldwide